Ms. Little is WRF Capital's investment manager for GlobeImmune, Targeted Growth, Pacific Bioscience Laboratories, Ultreo, Corus Pharma (acquired by Gilead Sciences), Amnis, Therus, EKOS, and Trace Detect.
Ms. Little is the investment manager and board observer of Accium Biosciences.